Log In
Print this Print this

Raplixa (formerly Fibrocaps)

  Manage Alerts
Collapse Summary General Information
Company Mallinckrodt plc
DescriptionDry powder topical fibrin sealant composed of fibrinogen and thrombin
Molecular Target
Mechanism of Action 
Therapeutic ModalityBiologic: Protein
Latest Stage of DevelopmentApproved
Standard IndicationBleeding
Indication DetailsTreat mild to moderate surgical bleeding
Regulatory Designation EU - Standard Review (Treat mild to moderate surgical bleeding)

 Product Details
 Archive Items are loading loading
Collapse Summary Deals Information
Total Number of DealsTotal Deal ValueTotal Upfront CashTotal Milestone Payments





 Deals Details
Get a free BioCentury trial today